Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-25 @ 2:18 AM
NCT ID:
NCT01352234
Eligibility Criteria:
Inclusion Criteria:
* Gestational age between 10 0 / 7 and 13 6 / 7 weeks
* History of preeclampsia (as defined by The Society of Obstetricians and Gynaecologists of Canada) confirmed by medical records
Exclusion Criteria:
* Negative Fetal Heart
* Multiple pregnancy
* Anaphylactic allergy to lactose
* Kown coagulopathy (antithrombin III deficiency, factor V Leiden, antiphospholipid syndrome, the prothrombin mutation, deficiency of protein S or protein C)
* Use of heparin or other anticoagulants.
* Contraindications to aspirin
* Severe fetal abnormality (cystic hygroma, nuchal translucency\> 95th percentile, anencephaly, etc.)
* History or active peptic ulcer
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01352234
Study Brief:
Protocol Section:
NCT01352234